Page 4 - கண்ணீர் படம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Powerful prescription relief for ocular itch from allergic conjunctivitis This article is sponsored by Eyevance Pharmaceuticals, developing innovative and impactful ophthalmic therapies for the ocular surface and anterior segment.  Allergic conjunctivitis (AC) is a common ocular condition. Worldwide, 15% to 20% of the population is affected by some form of allergic disease with ocular symptoms present in about 40% to 60% percent of those patients. More than a mere nuisance for many, ocular allergies have been shown to have an adverse impact on quality of life (QOL). In a cross-sectional study of 220 patients with ocular allergy, 25% had more than five episodes in the previous year and nearly 60% had episodes all year round. There was a significant impairment on overall QOL during an allergic conjunctivitis episode, with 46% rating their disease greater than 6 on a 10-point severity scale. Only 5.1% said their allergic conjunctivitis was mild or not severe. A total of 16% missed wo

United statesNutrition examination surveyNational healthDrug administrationEyevance pharmaceuticalsTear filmOcular surface societyDry eye workshopJohnson consumerஒன்றுபட்டது மாநிலங்களில்ஊட்டச்சத்து தேர்வு கணக்கெடுப்புதேசிய ஆரோக்கியம்கண்ணீர் படம்கண் மேற்பரப்பு சமூகம்உலர்ந்த கண் பணிமனைஜான்சன் நுகர்வோர்